Our Business Strategy into 2003: Product Development
Develop solids vs. liquids (unless indication warrants)
Tighter focus on the value added aspects for all programs
Pursuit of most realistic indications
Focus on clinical proof-of-concept through Phase II a
Partners to control and monitor large studies